Beyond ALK and ROS1: RET, NTRK, EGFR and BRAF gene rearrangements in non-small cell lung cancer

nork Farago, Anna F., Azzoli, Christopher G.
Argitaratua izan da Transl Lung Cancer Res (2017)

Current standards for clinical management of small cell lung cancer

nork Farago, Anna F., Keane, Florence K.
Argitaratua izan da Transl Lung Cancer Res (2018)

Crossover distribution and high interference for both the X chromosome and an autosome during oogenesis and spermatogenesis in Caenorhabditis elegans.

nork Meneely, Philip M, Farago, Anna F, Kauffman, Tate M
Argitaratua 2002

Redefining the central serotonergic system based on genetic lineage

nork Jensen, Patricia, Farago, Anna F., Awatramani, Rajeshwar B., Scott, Michael M., Deneris, Evan S., Dymecki, Susan M.
Argitaratua 2008

ATLANTIS: a Phase III study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one pr...

nork Farago, Anna F, Drapkin, Benjamin J, Lopez-Vilarino de Ramos, Jose Antonio, Galmarini, Carlos M, Núñez, Rafael, Kahatt, Carmen, Paz-Ares, Luis
Argitaratua izan da Future Oncol (2019)

CTNI-04. ACTIVITY OF LAROTRECTINIB IN TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION CANCER PATIENTS WITH CENTRAL NERVOUS SYSTEM (CNS) METASTASES

nork Patel, Jyoti D, Farago, Anna F, Hong, David S, Lassen, Ulrik N, Leyvraz, Serge, Park, Keunchil, Sohal, Davendra P S, Solomon, Benjamin, Reeves, John A, Dima, Laura, Brega, Nicoletta, Drilon, Alexander
Argitaratua izan da Neuro Oncol (2020)

Clonal Evolution and the Role of Serial Liquid Biopsies in a Case of Small-Cell Lung Cancer–Transformed EGFR Mutant Non–Small-Cell Lung Cancer

nork Mooradian, Meghan J., Piotrowska, Zofia, Drapkin, Benjamin J., Dias-Santagata, Dora, Marcoux, Nicolas, Arnaoutakis, Konstantinos, Nagy, Rebecca J., Lanman, Richard, Iafrate, Anthony J., Farago, Anna F., Mino-Kenudson, Mari, Hata, Aaron N., Sequist, Lecia V.
Argitaratua izan da JCO Precis Oncol (2017)

Regulatory T cells in tumor-associated tertiary lymphoid structures suppress anti-tumor T cell responses

nork Joshi, Nikhil S., Akama-Garren, Elliot H., Lu, Yisi, Lee, Da-Yae, Chang, Gregory P., Li, Amy, DuPage, Michel, Tammela, Tuomas, Kerper, Natanya R., Farago, Anna F., Robbins, Rebecca, Crowley, Denise M., Bronson, Roderick T., Jacks, Tyler
Argitaratua izan da Immunity (2015)

Treatment with Next-Generation ALK Inhibitors Fuels Plasma ALK Mutation Diversity

nork Dagogo-Jack, Ibiayi, Rooney, Marguerite, Lin, Jessica J., Nagy, Rebecca J., Yeap, Beow Y., Hubbeling, Harper, Chin, Emily, Ackil, Jennifer, Farago, Anna F., Hata, Aaron N., Lennerz, Jochen K., Gainor, Justin F., Lanman, Richard B., Shaw, Alice T.
Argitaratua izan da Clin Cancer Res (2019)

Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY...

nork Morgensztern, Daniel, Besse, Benjamin, Greillier, Laurent, Santana-Davila, Rafael, Ready, Neal, Hann, Christine L., Glisson, Bonnie S., Farago, Anna F., Dowlati, Afshin, Rudin, Charles M., Le Moulec, Sylvestre, Lally, Satwant, Yalamanchili, Sreeni, Wolf, Jürgen, Govindan, Ramaswamy, Carbone, David P.
Argitaratua izan da Clin Cancer Res (2019)

Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032

nork Ready, Neal, Farago, Anna F., de Braud, Filippo, Atmaca, Akin, Hellmann, Matthew D., Schneider, Jeffrey G., Spigel, David R., Moreno, Victor, Chau, Ian, Hann, Christine L., Eder, Joseph Paul, Steele, Nicola L., Pieters, Anne, Fairchild, Justin, Antonia, Scott J.
Argitaratua izan da J Thorac Oncol (2018)

The Art of Oncology: COVID‐19 Era

nork Reynolds, Kerry L., Klempner, Samuel J., Parikh, Aparna, Hochberg, Ephraim P., Michaelson, M. Dror, Mooradian, Meghan J., Lee, Richard J., Soumerai, Tara E., Hobbs, Gabriela, Piotrowska, Zofia, Sykes, David B., Farago, Anna F., Bardia, Aditya, Rosovsky, Rachel P., Ryan, David P.
Argitaratua izan da Oncologist (2020)

Genetic and Clonal Dissection of Murine Small Cell Lung Carcinoma Progression by Genome Sequencing

nork McFadden, David G., Papagiannakopoulos, Thales, Taylor-Weiner, Amaro, Stewart, Chip, Carter, Scott L., Cibulskis, Kristian, Bhutkar, Arjun, McKenna, Aaron, Dooley, Alison, Vernon, Amanda, Sougnez, Carrie, Malstrom, Scott, Heimann, Megan, Park, Jennifer, Chen, Frances, Farago, Anna F., Dayton, Talya, Shefler, Erica, Gabriel, Stacey, Getz, Gad, Jacks, Tyler
Argitaratua 2014

Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer

nork Farago, Anna F., Le, Long P., Zheng, Zongli, Muzikansky, Alona, Drilon, Alexander, Patel, Manish, Bauer, Todd M., Liu, Stephen V., Ou, Sai-Hong I., Jackman, David, Costa, Daniel B., Multani, Pratik S., Li, Gary G., Hornby, Zachary, Chow-Maneval, Edna, Luo, David, Lim, Jonathan E., Iafrate, Anthony J., Shaw, Alice T.
Argitaratua izan da J Thorac Oncol (2015)

Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in ROS1-Positive Non–Small-Cell Lung Cancer

nork Gainor, Justin F., Tseng, Diane, Yoda, Satoshi, Dagogo-Jack, Ibiayi, Friboulet, Luc, Lin, Jessica J., Hubbeling, Harper G., Dardaei, Leila, Farago, Anna F., Schultz, Katherine R., Ferris, Lorin A., Piotrowska, Zofia, Hardwick, James, Huang, Donghui, Mino-Kenudson, Mari, Iafrate, A. John, Hata, Aaron N., Yeap, Beow Y., Shaw, Alice T.
Argitaratua izan da JCO Precis Oncol (2017)

Brigatinib in Patients with Alectinib-Refractory ALK-Positive Non-Small Cell Lung Cancer: A Retrospective Study

nork Lin, Jessica J., Zhu, Viola W., Schoenfeld, Adam J., Yeap, Beow Y., Saxena, Ashish, Ferris, Lorin A., Dagogo-Jack, Ibiayi, Farago, Anna F., Taber, Angela, Traynor, Anne, Menon, Smitha, Gainor, Justin F., Lennerz, Jochen K., Plodkowski, Andrew J., Digumarthy, Subba R., Ou, Sai-Hong Ignatius, Shaw, Alice T., Riely, Gregory J.
Argitaratua izan da J Thorac Oncol (2018)

Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion–Positive Non–Small-Cell Lung Cancer

nork Dziadziuszko, Rafal, Krebs, Matthew G., De Braud, Filippo, Siena, Salvatore, Drilon, Alexander, Doebele, Robert C., Patel, Manish R., Cho, Byoung Chul, Liu, Stephen V., Ahn, Myung-Ju, Chiu, Chao-Hua, Farago, Anna F., Lin, Chia-Chi, Karapetis, Christos S., Li, Yu-Chung, Day, Bann-mo, Chen, David, Wilson, Timothy R., Barlesi, Fabrice
Argitaratua izan da J Clin Oncol (2021)

EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer (NSCLC): A Retrospective Analysis

nork Gainor, Justin F., Shaw, Alice T., Sequist, Lecia V., Fu, Xiujun, Azzoli, Christopher G., Piotrowska, Zofia, Huynh, Tiffany, Zhao, Ling, Fulton, Linnea, Schultz, Katherine R., Howe, Emily, Farago, Anna F., Sullivan, Ryan J., Stone, James R., Digumarthy, Subba, Moran, Teresa, Hata, Aaron N., Yagi, Yukako, Yeap, Beow Y., Engelman, Jeffrey A., Mino-Kenudson, Mari
Argitaratua izan da Clin Cancer Res (2016)

Clinicopathologic Features of Non–Small-Cell Lung Cancer Harboring an NTRK Gene Fusion

nork Farago, Anna F., Taylor, Martin S., Doebele, Robert C., Zhu, Viola W., Kummar, Shivaani, Spira, Alexander I., Boyle, Theresa A., Haura, Eric B., Arcila, Maria E., Benayed, Ryma, Aisner, Dara L., Horick, Nora K., Lennerz, Jochen K., Le, Long P., Iafrate, A. John, Ou, Sai-Hong I., Shaw, Alice T., Mino-Kenudson, Mari, Drilon, Alexander
Argitaratua izan da JCO Precis Oncol (2018)

Identification of DHODH as a therapeutic target in small cell lung cancer

nork Li, Leanne, Ng, Sheng Rong, Colón, Caterina I., Drapkin, Benjamin J., Hsu, Peggy P., Li, Zhaoqi, Nabel, Christopher S., Lewis, Caroline A., Romero, Rodrigo, Mercer, Kim L., Bhutkar, Arjun, Phat, Sarah, Myers, David T., Muzumdar, Mandar Deepak, Westcott, Peter M. K., Beytagh, Mary Clare, Farago, Anna F., Vander Heiden, Matthew G., Dyson, Nicholas J., Jacks, Tyler
Argitaratua izan da Sci Transl Med (2019)